Form 4: Sera Prognostics Director Mirza Mansoor Raza Reports RSU Vesting, Stock Option Grant, and Tax-Related Stock Sale

Sera Prognostics Director Mansoor Raza Mirza reported the vesting of restricted stock units, the grant of new stock options, and a subsequent sale of shares to cover tax obligations.

Summary

• Director Mansoor Raza Mirza acquired 15,596 shares of Class A Common Stock on June 5, 2025, through the vesting of restricted stock units (RSUs). These RSUs vest monthly over one year, starting June 5, 2025.
• On June 6, 2025, Mr. Mirza disposed of 107 shares of Class A Common Stock at a price of $1.58 per share. This sale was a non-discretionary "sell to cover" transaction to satisfy tax withholding obligations related to the RSU vesting.
• Mr. Mirza was also granted 25,000 stock options on June 5, 2025, with an exercise price of $1.60. These options vest monthly over one year, starting June 5, 2025, and expire on June 5, 2035.
• Following these transactions, Mr. Mirza beneficially owns 59,161 shares of Class A Common Stock and 25,000 stock options.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation for a director, including the grant of restricted stock units and stock options, which is generally positive as it aligns the director's interests with the company's performance. The subsequent sale of a small number of shares was a non-discretionary transaction to cover tax obligations, which is a neutral and expected event.

Positives

• The grant of 15,596 restricted stock units (RSUs) and 25,000 stock options to Director Mirza Mansoor Raza aligns his interests with shareholders and serves as an incentive for continued service.
• The stock options have a 10-year expiration date (June 5, 2035), providing a long-term incentive.

Negatives

• The sale of 107 shares of Class A Common Stock, although mandated for tax withholding, reduces the director's direct shareholding.

Future Outlook

The vesting schedules for both the restricted stock units and stock options indicate a continued monthly vesting over one year from June 5, 2025, contingent on the director's continued service.

Industry Context

This Form 4 filing details routine equity compensation transactions for a director, which is a common practice across publicly traded companies to align management and director interests with shareholders. It does not provide information on broader industry trends.

Comparison to Industry Standards

• The grant of restricted stock units and stock options as part of a non-employee director compensation policy is a standard practice in corporate governance across various industries, including the biotechnology and diagnostics sector where Sera Prognostics operates.
• The vesting schedule (1/12 monthly over one year) and the "sell to cover" mechanism for tax obligations are also common industry standards for equity compensation. Specific comparable companies or projects are not mentioned in this filing.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units and stock options to a director is a transaction between the company and a related party (director), conducted under established compensation policies.
• The "sell to cover" transaction is a mandated disposition of shares by the director to the company (or through the company's agent) to satisfy tax obligations arising from the RSU vesting.

Stakeholder Impact

• Shareholders: The equity grants to a director aim to align their interests with shareholders, potentially leading to better long-term performance. The "sell to cover" transaction has a negligible impact on share float.

Next Steps

• Monthly vesting of 1/12 of the 15,596 restricted stock units over one year, starting June 5, 2025.
• Monthly vesting of 1/12 of the 25,000 stock options over one year, starting June 5, 2025.

Key Dates

Keywords

Sera Prognostics, SERA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Options, Director Compensation, Equity Incentive Plan, Sell to Cover, Beneficial Ownership